期刊文献+

水痘-带状疱疹病毒糖蛋白E基因的原核表达及鉴定 被引量:1

Prokaryotic expression and identification of glycoprotein E of varicella-zoster virus
原文传递
导出
摘要 目的原核表达水痘-带状疱疹病毒(varicella-zoster virus,VZV)糖蛋白E (gE)基因,并对其进行鉴定。方法构建大肠埃希菌重组载体pET28a-gE-his,利用IPTG诱导表达gE蛋白,经亲和层析纯化得到蛋白,用免疫印迹法验证目的蛋白的特异性。结果 pET28a-gE-his/BL21的IPTG诱导表达产物利用亲和层析纯化除去杂蛋白后,获得相对分子质量约为60×10~3的纯化蛋白,并且能与鼠抗gE糖蛋白单抗发生特异性结合,证明该蛋白为gE目的蛋白。结论成功利用大肠埃希菌表达重组VZV糖蛋白E,并利用亲和层析柱进行有效的纯化,从而为VZV糖蛋白E的应用研究打下了基础。 Objective To express and identify the glycoprotein E(gE)of varicella-zoster virus(VZV)in prokaryotic cells. Methods The recombinant plasmid pET28 a-gE-his containing gene encoding VZV-gE was constructed to transform into E.coli.The recombinant E.coli was cultured and induced by isopropyl-β-d-thiogalactoside(IPTG)and the gE protein was purified using affinity chromatography column and the specificity was examined by Western blot. Results The product of pET28 a-gE-his/BL21 induced by IPTG was separated from the mix proteins by the affinity chromatography column,the relative molecular mass of the expressed protein is about 60×10-3.Western blot confirmed the specificity of glycoprotein E. Conclusions The recombinant VZV-gE was successfully expressed in E.coli.Purification of VZV glycoprotein E with affinity chromatography is an effective method.
作者 高媛 吴克 梁锦 李津 肖杨 GAO Yuan;WU Ke;LIANG Jin;LI Jin;XIAO Yang(Bravovax Co.,Ltd,Wuhan,Hubei 430074,China)
出处 《中国病毒病杂志》 CAS 2018年第5期389-392,共4页 Chinese Journal of Viral Diseases
基金 武汉市科学技术计划项目应用基础研究计划(2016060101010038)
关键词 水痘-带状疱疹病毒 糖蛋白E 原核表达 亲和层析 Varicella-zoster virus Glycoprotein E Prokaryotic expression Affinity chromatography
  • 相关文献

参考文献7

二级参考文献95

  • 1刘太华,张忠奎,许泽娟,罗陈.带状疱疹临床流行病学分析[J].西南军医,2005,7(6):28-30. 被引量:29
  • 2吴寰宇,张爱香,任宏,李燕婷.上海市部分地区儿童水痘疫苗免疫后流行病学效果观察[J].上海预防医学,2006,18(9):437-439. 被引量:44
  • 3Asano Y,Takahashi M. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children [ J ] . Pediatrics, 1977; 60(6) : 810-814
  • 4Weibel R, Neff B J, Kuter B J, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children [J]. N Engl J Med,1984; 310(22): 1409-1415
  • 5Varis T,Vesikari T. Efficacy of high titer live attenuated varicella vaccine in healthy young children [ J ]. J Infect Dis, 1996,174 ( Suppl 3 ) : S330-S334
  • 6Reynolds MA, Chaves SS, Harpaz R,et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: A review [ J ]. J Infect Dis, 2008 ; 197 ( Suppl 2) : S224-S227
  • 7Macartney KK, Burgess MA. Varicella vaccination in Australia and New Zealand [ J ]. J Infect Dis, 2008,197 (Suppl 2) : S191-S195
  • 8Seward JF, Marin M, Vaquez M. Varicella vaccine effectiveness in the US vaccination program: A review [J]. J Infect Dis,2008,197(Suppl Z) : S82-S89
  • 9Gomi Y,Sunamachi H,Mori Y,et al. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus[J]. J Virol,2002,76(5) : 11447- 11459
  • 10Gomi Y, Imagawa T, Takahashi M, et al. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varieella vaccine and its parental viruses[J]. Arch Virol Suppl,2001, (17): 49- 56

共引文献48

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部